Early research (Phase 1)WithdrawnNCT01320787What this trial is testing18-F-Fluoroacetate as PET Imaging AgentWho this might be right forBrain CancerBreast CancerProstate Cancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07070232What this trial is testingA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 1,438
Early research (Phase 1)UnknownNCT05775666What this trial is testingUCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid TumorsWho this might be right forSolid Tumor Peking University 87
Early research (Phase 1)Looking for participantsNCT05471856What this trial is testingTest How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)Who this might be right forSolid Tumors Boehringer Ingelheim 66
Early research (Phase 1)Study completedNCT04617314What this trial is testingRC108-ADC in Subjects With Advanced Malignant Solid TumorsWho this might be right forSolid Tumor RemeGen Co., Ltd. 67
Early research (Phase 1)Study completedNCT03421353What this trial is testingAZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerWho this might be right forAdvanced Solid Tumours AstraZeneca 76
Early research (Phase 1)Ended earlyNCT05098405What this trial is testingFirst-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor Molecular Partners AG 46
Testing effectiveness (Phase 2)Study completedNCT04082572What this trial is testingPembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid CancersWho this might be right forLocally Advanced Malignant Solid Neoplasm M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT03508011What this trial is testingIMP4297 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumoursBreast CancerOvarian Cancer+1 more Impact Therapeutics, Inc. 57
Testing effectiveness (Phase 2)Looking for participantsNCT02029001What this trial is testingAdapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatmentWho this might be right forMalignant Solid Neoplasms Centre Leon Berard 900
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865What this trial is testingTesting MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Looking for participantsNCT07192107What this trial is testingMHB042C in Patients With Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor Minghui Pharmaceutical (Hangzhou) Ltd 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136What this trial is testingTesting Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00052338What this trial is testingBortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerWho this might be right forMalignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT00250978What this trial is testingPh I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLCWho this might be right forCarcinoma, Non-Small-Cell Lung Memorial Sloan Kettering Cancer Center 15
Large-scale testing (Phase 3)UnknownNCT00003034What this trial is testingONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy RegimenWho this might be right forMalignant Mesothelioma Alfacell 300
Not applicableLooking for participantsNCT07737509What this trial is testingUnderstanding the Genetic and Biological Factors That Influence Cancer Treatment Response and Resistance in Patients With Advanced Solid Tumours Through Sample AnalysisWho this might be right forAdvanced Solid Tumours Institute of Cancer Research, United Kingdom 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263What this trial is testingA Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid TumorsWho this might be right forRecurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more Tasly Biopharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07805252What this trial is testingTrial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With CancerWho this might be right forAdvanced Solid Tumors Cancer Orion Corporation, Orion Pharma 195
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249What this trial is testingPhase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplastic Disease Mirati Therapeutics Inc. 731